UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000051096
Receipt number	R000058218
Scientific Title	Innovation of the 1st line strategy optimized as abemaciclib with endocrine therapy based on the ESR1 mutation of ctDNA for HR-positive HER2-negative advanced metastatic breast cancer patients - Multi-institutional phase 2 trial
Date of disclosure of the study information	2023/05/18
Last modified on	2023/05/18 13:50:18

---